Otomidone (Procaine Hydrochloride, Phenazone)

Otomidone, containing procaine hydrochloride, is used to provide local anesthesia in several clinical situations.

• Ear pain (otalgia): reduces discomfort by numbing the external auditory canal.
• Minor skin surgery: creates temporary loss of sensation for incision or biopsy.
• Dental procedures: topical anesthesia of oral mucosa for procedures such as scaling.
• Endoscopic procedures: anesthetizes mucosal surfaces during diagnostic examinations.
• Burn debridement: alleviates pain during superficial burn cleaning.

• Procaine hydrochloride acts as a reversible sodium‑channel blocker. By binding to the intracellular portion of voltage‑gated Na⁺ channels in neuronal membranes, it prevents the influx of sodium ions during depolarisation, thereby inhibiting the generation and propagation of nerve impulses. Phenazone contributes analgesic and anti‑inflammatory effects through inhibition of cyclo‑oxygenase enzymes, enhancing the overall pain‑relieving action. The combined effect results in rapid onset of numbness and short‑duration analgesia suitable for brief procedures.

Adverse reactions to Otomidone are generally related to its local anesthetic and analgesic components.

Common Side Effects

• Local irritation: mild redness or itching at the application site.
• Burning sensation: transient warmth or stinging when applied.
• Dizziness: occasional light‑headedness.
• Nausea: mild gastrointestinal upset.
• Headache: brief headache episodes.

Serious or Rare Side Effects

• Allergic reaction: rash, swelling, or urticaria indicating hypersensitivity.
• Anaphylaxis: severe, potentially life‑threatening systemic reaction.
• Methemoglobinemia: rare blood disorder causing cyanosis.
• Cardiac arrhythmia: irregular heartbeat due to systemic absorption.
• Seizures: rare central nervous system excitation.

When using Otomidone, several safety considerations should be observed to minimise risks.

• Allergy assessment: confirm no known hypersensitivity to procaine, phenazone or related compounds.
• Infection control: avoid application on infected or inflamed skin and mucosa.
• Area limitation: restrict use to the recommended surface area to prevent systemic toxicity.
• Cardiac caution: use with care in patients with known heart conduction disorders.
• Drug interactions: review concomitant medications that may potentiate local anesthetic toxicity.
• Store at room temperature: keep in original container, protect from light and moisture.

Otomidone may interact with other medicines, influencing its safety or effectiveness.

Major Interactions (Avoid)

• MAO inhibitors: phenazone can precipitate hypertensive crisis.
• Beta‑blockers: may enhance procaine‑induced cardiac conduction effects.
• Other local anesthetics: additive toxicity risk when combined.

Moderate Interactions (Monitor Closely)

• Anticoagulants: increased bleeding risk if mucosal trauma occurs.
• CNS depressants: may augment sedation when systemic absorption occurs.
• Diuretics: can alter plasma concentrations of procaine.